Good morning :)
Switch to
Place Order

Alkem Laboratories Ltd

ALKEM
Health CarePharmaceuticals
MidcapWith a market cap of ₹45,287 cr, stock is ranked 103
Low RiskStock is 1.38x as volatile as Nifty
3,805.9018.20 (+0.48%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹45,287 cr, stock is ranked 103
Low RiskStock is 1.38x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
28.57
PB RatioPB Ratio
5.99
Dividend YieldDiv. Yield
0.79%
Sector PESector PE
39.78
Sector PBSector PB
5.33
Sector Div YldSctr Div Yld
0.65%

Forecast & RatingsDetailed Forecast 

71%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Alkem Laboratories Limited is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.

Brands

Alkem Labs

Pharmaceutical company

Investor PresentationView older 

Aug 6, 2021

PDF
View Older Presentations

Brands

Alkem Labs

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020216.527.448.459.100.630.761.131.59
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 3.59%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 1.51%

See detailed holdings

Recent EventsAll events 

Updates 
Announced OnSep 20, 2021

Alkem Laboratories Limited has informed the Exchange regarding ' Closure of operations at Beta Block (Unit II) manufacturing facility located at Baddi. Details required to be submitted under Regulation 30 of SEBI Listing Regulations are enclosed herewith.'. | Download

Alkem Laboratories Limited has informed the Exchange regarding ' Closure of operations at Beta Block (Unit II) manufacturing facility located at Baddi. Details required to be submitted under Regulation 30 of SEBI Listing Regulations are enclosed herewith.'. | Download

Shareholders meeting 
Announced OnAug 27, 2021

Alkem Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 27, 2021. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. | Download

Alkem Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 27, 2021. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. | Download

Cash Dividend 
Ex. DateAug 9, 2021

Final • Div/Share: ₹ 5

See all events